Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr), the intended drug target.
Procrastination§v. Architecture of Ethics§vi. Situations and Significance§vii. Truth and Honesty§viii. The Comprehensible and the Incomprehensible and Social Alignment§ix.
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the Navigator study